Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease
Public ClinicalTrials.gov record NCT02646488. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to evaluate the effectiveness of practice facilitation as a quality improvement strategy for implementing the Million Hearts' ABCS treatment guidelines for reducing cardiovascular disease (CVD) among high-risk patients who receive care in primary care practices in New York City. The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S). The long-term goal is to create a robust infrastructure to disseminate and implement evidence based practice guidelines (EBPG) findings in primary care practices and improve practices' capacity to receive and implement other EBPG findings in the future.
Study identification
- NCT ID
- NCT02646488
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 276 participants
Conditions and interventions
Conditions
Interventions
- Million Hearts ABCS 6 Months Behavioral
- Million Hearts ABCS 9 Months Behavioral
- Million Hearts ABCS 12 Months Behavioral
- Million Hearts ABCS 15 Months Behavioral
- Standard Care Regimen 9 Months Behavioral
- Standard Care Regimen 12 Months Behavioral
- Standard Care Regimen 15 Months Behavioral
- Standard Care Regimen 18 Months Behavioral
- Standard Care Regimen 21 Months Behavioral
- Standard Care Regimen 24 Months Behavioral
- Standard Care Regimen 27 Months Behavioral
- Follow Up Post Intervention 21 Months Behavioral
- Follow Up Post Intervention 24 Months Behavioral
- Follow Up Post Intervention 27 Months Behavioral
- Follow Up Post Intervention 30 Months Behavioral
- Follow Up Post Intervention 33 Months Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2015
- Primary completion
- Mar 31, 2019
- Completion
- Mar 31, 2019
- Last update posted
- May 19, 2019
2015 – 2019
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| New York University School of Medicine | New York | New York | 10016 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02646488, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 19, 2019 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02646488 live on ClinicalTrials.gov.